Conference and earnings call announcements

WILMINGTON, Del., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (NASDAQ:PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Chardan Healthcare Conference taking place in New York City on October 20, 2026. On Tuesday, October 20, 2026, at 2:00 p.m. ET, Peggy Scherle, Ph.D., Chief Scientific Officer of Prelude and Bryant Lim, Chief Financial Officer, will participate in a fireside chat. A live webcast of the fireside chat can be accessed on the Company’s website under Events and Presentations. The recording will be archived and available on the Company’s website for 90 days. About Prelude Therapeutics

SALT LAKE CITY, Oct. 16, 2026 /PRNewswire/ -- FatPipe, Inc. (NASDAQ:FATN) ("FatPipe" or the "Company"), a pioneer in enterprise-class software-defined wide area networking, cybersecurity and network observability solutions, is pleased to announce that it will host an investor webinar to present its financial results for the second quarter of fiscal year 2027. The investor webinar will be held on November 4, 2026, from 4:30 PM to 5:00 PM Eastern Time. Senior management will review the Company's Q2 financial performance and provide business updates, followed by a brief question-and-answer session.Event DetailsDate: November 4, 20

NEW YORK, NY, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Fabric.AI (NASDAQ:FABC) ("Fabric.AI" or the "Company"), an AI infrastructure company developing a suite of fabless semiconductor technologies for next-generation AI factories, today announced that James Altucher, Fabric.AI’s Senior Strategic Advisor, will join Michael Murray, Chief Executive Officer, President and Chairperson of its development partner Kopin Corporation (NASDAQ:KOPN), and AI expert Cortney Harding for a live YouTube "Ask Me Anything" panel. Hosted by Kopin and titled "The Trillion Dollar AI Bottleneck," the event will stream live from Nasdaq MarketSite in New York City on October 20, 2026, at 11:00 a.m. EDT. The event will e

JACKSONVILLE, Fla., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. ("Duos" or the "Company") (NASDAQ:DUOT), a provider of adaptive, modular architecture data center colocation and infrastructure solutions, today announced that it will participate in the 20th Annual LD Micro Main Event being held from October 19-21, 2026 at the Luxe Sunset Blvd Hotel in Los Angeles, CA. Duos management will host a presentation on Tuesday, October 20 at 1:00 p.m. Pacific Time. The presentation will be webcast and available for replay here. Management will also be available for one-on-one and small-group meetings with institutional investors throughout the day. Those interested in scheduli

STUART, Fla., Oct. 16, 2026 /PRNewswire/ -- Health In Tech, Inc. (NASDAQ:HIT) ("Health In Tech" or the "Company") will host its 2026 Annual Meeting of Stockholders (the "2026 Annual Meeting") on Tuesday, November 10, 2026, at 10:00 AM ET via live virtual webcast. At the 2026 Annual Meeting, holders of Company stock as of the close of business on September 18, 2026 (the "Record Date") will be able to vote their shares electronically and submit questions during the meeting.To participate in the 2026 Annual Meeting, such stockholders as of the Record Date should visit www.cleartrustonline.com/HIT. Guests may also access the 2026 A

CHARLOTTE, N.C., Oct. 16, 2026 /CNW/ -- Truist Financial Corporation (NYSE:TFC) reported its third quarter 2026 results today. Investors can access the live third quarter 2026 earnings call at 8 a.m. ET today by webcast or dial-in as follows:Webcast:app.webinar.net/BAM6O91OpkLDial-in: 1-877-883-0383, passcode 2090022The earnings release, investor presentation, including an appendix reconciling non-GAAP disclosures, and Truist's Third Quarter 2026 Quarterly Performance Summary, which contains detailed financial schedules, are available at Truist's Investor Relations website at https://ir.truist.com/earnings. A replay of the call will be available on the website for 30 days.About Truist Truist

MakeMyTrip Limited (NASDAQ:MMYT) plans to report its fiscal 2027 second quarter financial and operating results before markets open on Monday, October 26, 2026. The company will post the release on its Investor Relations website at https://investors.makemytrip.com/ and will not distribute over newswires.A live Zoom Webinar with the senior management team will also be hosted on October 26, 2026, at 7:30 am EDT or 5:00 pm IST through the company’s Investor Relations website at https://investors.makemytrip.com/.To register for the webinar, please follow this link: https://makemytrip.zoom.us/webinar/register/WN_j6vUmgNWSH6mvB_YJfm4AARegistered participants will receive a confirmation email conta

MSCI to consult on proposal to reclassify the MSCI Indonesia Indexes to Standalone Market status Existing freeze on Indonesian securities in MSCI Indexes to remain in place until further notice MSCI announced the launch of a consultation on a proposal to reclassify the MSCI Indonesia Indexes from Emerging Market to Standalone Market status. MSCI will announce its final decision by the end of June 2027 and may provide an interim update on market participant feedback during the consultation period. As part of the June 2026 Market Classification Review, MSCI reported that market participants had raised significant concerns regarding the investability of the Indonesian equity market, i

New Platform Helps Scholarship Granting Organizations Support Students Across Public and Private SchoolsLINCOLN, Neb., Oct. 15, 2026 /PRNewswire/ -- FACTS, a Nelnet company (NYSE:NNI), today announced FACTS Compass™, a scholarship administration platform designed to help Scholarship Granting Organizations (SGOs) administer the Federal Scholarship Tax Credit (FSTC) and build a more connected scholarship management experience.The FSTC creates a new opportunity for eligible taxpayers to support scholarships that help families cover qualifying educational expenses for students attending public and private schools. FACTS Compass is designed to help SGOs establish the operational foundation needed

TOKYO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- CTW (NASDAQ:CTW) ("CTW" or "the Company"), a leading game platform company providing global access to web-based games through its flagship platform, G123.jp, today reported financial results for the fiscal year ended July 31, 2026 ("FY26"). Financial and Business Highlights Generated revenue of $82.5 million in FY26, down 9% YoY, while increasing segment profits 3% YoY to $32.3 million, or 33.4% of in-game purchases (up from 29.3% in FY25)Reduced advertising expense by $11.4 million, or 22% YoY, a notably larger decline than revenue, reflecting CTW’s ROAS-focused business model and disciplined approach to marketing spendGrew revenue from users out

NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc ("LB Pharmaceuticals" or the "Company") (NASDAQ:LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced that members of its executive team will present and participate in the following upcoming investor conferences: Craig-Hallum Biotech Catalyst Conference Virtual fireside chat at 10:00 a.m. ET and virtual 1x1 investor meetings on Thursday, October 22, 2026 Guggenheim Securities 3rd Annual Healthcare Innovation Conference Fireside chat at 1:00 p.m. ET and 1x1 investor meetings

CAMBRIDGE, Mass., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (NASDAQ:SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, today announced that Esther Rajavelu, Spero's President and Chief Executive Officer, will participate in a fireside chat at the Chardan 10th Annual Healthcare Conference to be held in New York City, on October 20th, 2026. Spero's leadership team will also be available for one-on-one meetings at the conference. Presentation Details Date / time: October 20, 2026, 9:15 AM ETFormat: Fireside chatLocation:Holmes II, Lotte New York PalaceWebcast LinkHere   The webcast may also be acces

Spruce Biosciences, Inc. (NASDAQ:SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will participate in a fireside chat at the Craig-Hallum Biotech Catalyst Conference on October 22, 2026. An archived copy of the webcast will be available on the events section of the Company’s website for approximately 90 days following the live presentation. About Spruce Biosciences Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neur

Investor Conference for Micro/Small-Cap Public Companies to Be Held in L.A. From 10/19 - 10/21 Comstock Holding Companies, Inc. (NASDAQ:CHCI) ("Comstock" or the "Company"), a leading real estate company specializing in the development, acquisition, operation, and management of mixed-use, transit-oriented properties and data center developments, today announced that members of its leadership team will participate in the LD Micro 20th Annual Main Event, taking place October 19-21 at the Luxe Sunset Boulevard Hotel in Los Angeles, Ca. Founded in 2006 and hosted by LD Micro (a subsidiary of Freedom Holding), the LD Micro Main Event serves as a critical resource for connecting institutional

CHARLOTTE, N.C., Oct. 15, 2026 /PRNewswire/ -- Ally Financial (NYSE:ALLY) Chief Financial Officer Russ Hutchinson will present at the BancAnalysts Association of Boston Conference on Thursday, November 5, 2026 at approximately 9:35 a.m. ET.A live webcast will be available on the day of the conference at http://www.ally.com/about/investor/ under the Events and Presentations section of the Investor Relations website. A replay will also be available.About Ally FinancialAlly Financial Inc. (NYSE:ALLY) includes the nation's largest all-digital bank and an industry leading auto finance business, driven by a mission to "Do It Right" for its customers and communities. Ally is a U.S. financial holdin

RANCHO CUCAMONGA, Calif., Oct. 15, 2026 (GLOBE NEWSWIRE) -- iPower Inc. (NASDAQ:IPW) ("iPower" or the "Company") today announced that its wholly owned subsidiary, iPower AI LLC, has received a customer-signed, non-binding letter of intent for a five-year AI equipment services and management relationship. The proposed engagement marks a step forward in iPower’s transformation into an AI infrastructure and services company. The customer has identified an initial fleet of 48 AI computing equipment units and expects to expand to approximately 396 units in total during 2027. At the proposed fee of $4,608 per unit per month, assuming the full build out, the target fleet would represent up to ap

NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Our Bond, Inc. ("Bond") (NASDAQ:OBAI), the creator of the world’s first AI-powered Preventative Personal Security platform adopted by leading multinational companies, today announced that Founder and CEO Doron Kempel will host a live investor webinar on Tuesday, October 20, 2026, at 11:00 AM Eastern Time. Investors and members of the media are encouraged to participate. Mr. Kempel plans to highlight recent business momentum and key corporate developments, while providing insight into the Company’s ongoing growth initiatives and outlook. Interested parties are encouraged to submit questions in advance to investorrelations@ourbond.com. The Compan

Combined total revenues plus interest income of approximately $47.0 million for the companies’ most recent fiscal years (AtlasClear FYE June 30, 2026; Dawson James FYE December 31, 2025) — more than double AtlasClear’s standalone fiscal 2026 total revenues plus interest income of $21.9 million*Dawson James, Ark’s principal operating subsidiary, was profitable in 2025, with audited net income of approximately $2.4 millionAtlasClearing (AtlasClear’s correspondent clearing subsidiary) and Dawson James were each in compliance with their net capital requirements, with approximately $14.4 million and $3.6 million of net capital at June 30, 2026, and July 31, 2026, respectivelyAdds a nationally ran

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), a fully integrated commercial-stage biotechnology company advancing genetic medicines for rare and life-threatening diseases, focused on inherited cardiovascular disorders, today announced that the company will attend Chardan’s 10th Annual Healthcare Conference. The company will participate in a panel on Tuesday, October 20, 2026, at 11:30 AM ET and host investor meetings. About Rocket Pharmaceuticals, Inc. Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) is a fully integrated commercial-stage biotechnology company developing genetic medicines for rare and life-threatening diseases, with a strategic focus on inherited cardiovascular disorders and ad

Partnership Enables Rural Fiber and Fixed Wireless Provider to Expand Customer Services Through FreeCast's Software-Based Streaming, Advertising and Commerce Platform FreeCast, Inc. (NASDAQ:CAST), a provider of software-based media distribution and monetization technology, today announced a distribution partnership with Cajun Broadband, a Louisiana-based provider of fiber-optic and fixed wireless broadband services. The agreement will enable Cajun Broadband to offer FreeCast's streaming and media marketplace capabilities to customers across its Louisiana service areas, including underserved rural communities, while creating opportunities for additional revenue streams beyond traditional

SÃO PAULO, Oct. 14, 2026 (GLOBE NEWSWIRE) -- PicPay (NASDAQ:PICS) will participate in Money 20/20 USA on Monday, October 19, 2026, in Las Vegas, Nevada. PicPay senior leadership, including CEO Eduardo Chedid, CFO Andre Cazotto, EVP SMB Renata Greco, and EVP Audience and Ecosystem Alexandre Moshe will participate in sessions including a fireside chat and a hosted lunch featuring a discussion on connected banking and the practical use of AI in financial services. Session details: Fireside chat: "Brazil Figured Out First: Connected Banking Experience." From 11:10 to 11:30 a.m. PT on The Intersection Stage, PicPay CEO Eduardo Chedid will join Candelaria Villagra, Head of Banking as a Ser

BXP, Inc. (NYSE:BXP), the largest publicly traded developer, owner, and manager of premier workplaces in the United States, announced today that it has closed the sale of a 10.6% equity interest in the development of 343 Madison Avenue in Midtown Manhattan, New York, to AVRS Partners, a New York-based real estate investment firm specializing in identifying and acquiring exceptional real estate assets across the United States and Europe. "343 Madison Avenue demonstrates the strength of BXP’s development platform and our ability to execute complex projects that create value for our shareholders and joint venture partners," said Owen Thomas, Chairman and Chief Executive Officer, BXP. "With t

NEW YORK, Oct. 14, 2026 /PRNewswire/ -- TEN Holdings, Inc. ("XHLD" or the "Company") (Nasdaq: XHLD), the technology company behind TEN, a Digital Experience Platform for creating, producing, engaging, marketing and measuring digital experiences, today announced that the Company will be presenting at the LD Micro 20th Annual Main Event on October 21, 2026, at 11:00 AM PT at the Luxe Sunset Boulevard Hotel. TEN Holdings Chief Executive Officer, Virgilio Torres, will be presenting on behalf of the Company and meeting with investors throughout the conference."We are thrilled to present at the LD Micro's Annual Main Event," commented Virgilio Torres, CEO. "As TEN Holdings continues to expand its

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD), today announced that Chief Executive Officer Michael Castagna will participate in a panel focused on innovation across chronic respiratory diseases at the Chardan Healthcare Conference. Management will also participate in one-on-one meetings with investors during the conference. Panel: Idiopathic Pulmonary Fibrosis & Chronic Respiratory Disease: Antifibrotics, CF, Bronchiectasis & COPD InnovationDate: Tuesday, October 20, 2026Time: 2:00–2:30 p.m. ET A live webcast of the panel discussion will be available on the Events & Presentations section of MannKind’s Investor Relations

Management to Provide Company Overview and Discuss Business Strategy, Recent Developments, and Growth Opportunities NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- AIB Data Centers Inc. (NYSE:AIB) ("AIB" or the "Company"), a developer and operator of digital infrastructure focused on artificial intelligence ("AI") and high-performance computing ("HPC") workloads, today announced that Chief Executive Officer Jerry Tang and Chief Financial Officer Jolienne Halisky will host a virtual investor webinar on Thursday, October 22, 2026, at 4:15 p.m. ET. The event is open to all investors and interested parties. During the webinar, management will provide an overview of AIB’s business model, developm

TruConfidence brings AI-powered remediation intelligence to help organizations eliminate cyber risk at machine speed and increase confidence in business resiliency FOSTER CITY, Calif., Oct. 14, 2026 /PRNewswire/ -- Qualys, Inc. (NASDAQ:QLYS), a pioneer of cloud-native cyber risk management, today announced TruRisk Eliminate™ 2.0 with TruConfidence™, a new remediation intelligence and orchestration engine that powers Qualys' vision for Autonomous RemOps, a new category for the frontier AI era. Built on Qualys' extensive experience of deploying half a billion patches with less than 0.1% rollback, of which 40% were deployed autonomously, TruRisk Eliminate combines the latest advances in autonom

CAMBRIDGE, Mass., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced two poster presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress, to be held October 27-30, 2026, in Hamburg, Germany. European Society of Gene and Cell Therapy (ESGCT) CongressTitle: Novel targeted LNP delivery achieved in vivo CAR-T cell generation resulting in therapeutically relevant B-cell depletionSession Date and Time: Wednesday, October 28, 2026, 1:30 - 3:30 p.m. CETSession Title: Poster Session 1Presenter: Harry An, Director, Process Deve

Questions Legitimacy of Incumbent Board Following Overwhelming Stockholder Withhold Vote; Calls for Independent Oversight and Materially Improved Tender Offer Terms Announces that Bastion Trading Will Not Participate in the Proposed Tender Offer Unless Its Concerns Are Satisfactorily Addressed NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Bastion Trading Limited ("Bastion Trading," "we" or "our"), a major stockholder of SkyAI, Inc. (NASDAQ:SKYA) ("SkyAI" or the "Company") that, together with certain of its affiliates, beneficially owns approximately 9.99% of the Company’s outstanding common stock, today expressed serious concerns regarding SkyAI’s proposed cash tender offer announced on Oc

Report Examines Governance Milestones and Continued Institutional AdoptionCompany to Host Publicly Available Webinar on October 21NEW YORK, Oct. 14, 2026 /PRNewswire/ -- Canton Strategic Holdings, Inc., (NASDAQ:CNTN) ("Canton Strategic Holdings" or the "Company") the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize traditional financial markets, today announced the release of its ecosystem report for the third quarter of 2026. The Company will discuss the report during a live webinar on October 21, 2026 at 11:00 a.m. ET.With a review of institutional participation, asset issuance, and governance updates,  the report lays out the most s

MALTA, N.Y., Oct. 14, 2026 (GLOBE NEWSWIRE) -- GlobalFoundries (NASDAQ:GFS) (GF) today announced it has been selected as the technology provider and operator for two new semiconductor manufacturing facilities ("fabs") at its Malta, New York, site under a U.S.-Japan initiative providing up to $21 billion in funding. Enabled by President Donald J. Trump's trade and investment agreement with Japan, the initiative will accelerate trusted semiconductor manufacturing in the United States, strengthen critical supply chains and support growing demand across automotive, industrial and connected infrastructure markets. Japan will provide the investment, while GF will contribute its differentiated t

OLD GREENWICH, Conn., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR) ("Star" or the "Company"), a diversified holding company, announced today that its management team will present at the LD Micro Main Event, which will take place from October 19-21, 2026 in Los Angeles. Star’s main presentation is scheduled for Tuesday, October 20, at 9:30am PT/12:30pm ET. Investors can access the live presentation by clicking here.  Management will also host one-on-one meetings with investors during both days. Investors can download a PDF copy of the presentation by visiting Star’s Investor Relations section of the website www.starequity.com. About Star Equity Holdings, In

MIAMI, Oct. 14, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced that members of its management team will participate in the upcoming Chardan 10th Annual Healthcare Conference: Date: October 20, 2026Time: 11:15 - 11:30 a.m. ETFormat: Fireside Chat Presenter: Samuel J. Reich, Chief Executive OfficerLocation: New York, NYWebcast: Register here SAB BIO management will be available for one-on-one meetings during the conference. Interested parties should contact their conference representative to arra

HOUSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. ("Tvardi" or the "Company") (NASDAQ:TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases, today announced that management will present at Chardan’s 10th Annual Healthcare Conference in New York City on Tuesday, October 20, 2026, at 1:30 PM ET. Members of the Tvardi management team will be available to meet with investors who are registered to attend the conference. About Tvardi Therapeutics Tvardi is a clinical-stage biopharmaceutical company focused on the development of novel, oral small mo

SAN DIEGO and SUZHOU, China, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (NASDAQ:ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced that Adagene’s Chief Executive Officer and President of R&D, Peter Luo, Ph.D., will participate in a fireside chat at the H.C. Wainwright 4th Annual Immune Cell Engager Virtual Conference being held virtually on October 15, 2026. H.C. Wainwright 4th Annual Immune Cell Engager Virtual ConferenceFormat: Fireside chatDate: October 15, 2026Time: 1:30 – 2:00 p.m. ET A webcast of the fireside chat will be accessible in the Investors section of the Company’s

BOSTON and JOHANNESBURG, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of technology-enabled care, today published a new case study on Discovery Health’s use of SilverCloud® by Amwell® to deliver a fully funded digital mental health benefit in South Africa. The case study examines the three questions health plans ask of digital care: whether members will use it, whether it improves their health, and what it does to costs. In the program's first 12 months, 22,000 Discovery Health members activated the benefit. Members with moderate, moderately severe or severe depression at baseline, and members with moderate or severe anxiety, showed clinically significant impr

WATERTOWN, Mass., Oct. 14, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4") (NASDAQ:CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that the company will participate in a panel during Chardan’s 10th Annual Healthcare Conference on October 20, 2026. Details below: Chardan’s 10th Annual Healthcare Conference TitleRNA Medicines: Transcriptome EngineeringFormatPanelDate and TimeOctober 20, 2026 | 9:15-9:45 a.m. EDTLocationNew York, NYWebcast linkClick Here   The eve

TrueBlue (NYSE:TBI), a leading provider of specialized workforce solutions, today announced that President and CEO Taryn Owen and CFO Carl Schweihs will participate in the JPM Ultimate Services Investor Conference on Tuesday, November 17th, 2026. Management will host in-person investor meetings throughout the day. About TrueBlue TrueBlue (NYSE:TBI) is a leading provider of specialized workforce solutions. As The People Company®, we put people first–advancing our mission to connect people and work while delivering smart, scalable solutions that help businesses grow and communities thrive. Since our founding, TrueBlue has connected more than 10 million people with work and served over 3 mil

Expects 2026 revenue of approximately €16 million to €18 million compared to €14.4 million in revenue in 2025, with a lower non-IFRS adjusted operating loss and increased net assetsCompleted acquisition of Royal Uranium Inc. on July 21, 2026, adding royalty and similar interests in 16 uranium-focused and three natural gas project areas, including exposure to Canada's Athabasca BasinBrightHy Solutions began execution of a 2 MW industrial green hydrogen project in Spain and contributed approximately €369,000 in first-half 2026 engineering revenueAl Shola Gas signed approximately $3.5 million in new LPG engineering subcontracts in the first half of 2026 and, in September 2026, expanded its LPG

Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("FFAI") and FF EAI Robotics Ecosystem Inc. (NASDAQ:FFR) (formerly AIxCrypto Holdings, Inc. and AIXC) ("FFR") signed definitive agreements on October 12, 2026, for FFR to acquire FFAI’s robotics assets and business in an all-stock transaction. FFR to become the First U.S.-Listed Pure-Play Humanoid and Bionic EAI Robotics Company under the agreement. The parties agreed on a valuation of approximately $200 million for FFAI’s robotics business and approximately $60 million for FFR on a fully diluted basis. The closing is expected to be completed by the end of October 2026. FFR will issue shares to FFAI at $2.246 per share, repres

Arrowhead’s TRiM™ platform achieves clinical validation for delivery of siRNA that crosses the blood-brain barrier after subcutaneous injection ARO-MAPT demonstrates mean cerebrospinal fluid total tau reduction of 73% on Day 105, with a maximum individual reduction of 85%, supporting the potential for quarterly dosing Arrowhead will host a webinar today, October 14, at 2:30 PM ET/11:30 am PT to review additional interim results Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced interim results from an ongoing Phase 1/2a study of ARO-MAPT, the company’s investigational RNA interference (RNAi) therapeutic being developed as a potential treatment for Alzheimer’s disease an

VS-7375 900 mg QD monotherapy achieved a 41% confirmed ORR in the broader 2L+ pancreatic ductal adenocarcinoma (PDAC) patient population and a 36% confirmed ORR in 3-4L; responses are durable with a majority of patients ongoing >6 months and a 67% landmark 6-month PFS rate FDA alignment reached on Phase 3 trial design in 1L mPDAC; plan to open trial by year-end Early results in heavily pretreated 3L+ colorectal cancer (CRC) include 33% unconfirmed ORR with 900 mg QD in combination anti-EGFR therapy with no patients with target lesion increases VS-7375 achieved 43% confirmed ORR with 600 mg QD monotherapy in 2L+ non-small cell lung cancer (NSCLC) including patients with prior taxane tr

MAHWAH, N.J., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Radware® (NASDAQ:RDWR), a global leader in AI and application security and delivery solutions for multi-cloud environments, today announced Radware Model Context Protocol (MCP) Server Protection, a purpose-built solution designed to help organizations more securely adopt MCP as AI agents gain greater access to enterprise applications, data and business workflows. The solution is intended to give organizations visibility into their MCP infrastructure, help protect MCP servers against MCP-specific attacks and establish governance as deployments scale. MCP is rapidly emerging as a standard way for AI agents to connect to enterprise applications

PERTH, Australia, Oct. 13, 2026 (GLOBE NEWSWIRE) -- via IBN -- Globavend Holdings Limited (NASDAQ:GVH) ("Globavend" or the "Company"), an emerging e-commerce logistics provider and AI-powered digital entertainment company, today announced that its Chairman, Kenny K.M. Fung, will present at the 2026 ThinkEquity Conference on Thursday, October 15, 2026, at the Mandarin Oriental Hotel in New York City. Mr. Fung will provide an overview of Globavend’s business, recent developments and growth strategy, highlighting the Company’s established cross-border logistics operations alongside its expansion into digital and live entertainment through Loomi Entertainment Group Limited. The presentation

NorthWestern Energy Group, Inc. d/b/a NorthWestern Energy (NASDAQ:NWE) today announced that it will host an investor webinar on Thursday, November 5, 2026, at 11:00 a.m. Eastern to review its financial results for the quarter ending September 30, 2026. The Company also plans to issue a news release detailing its financial results the evening of Wednesday, November 4, 2026. To register for the webinar, please visit https://northwesternenergy.com/earnings-registration. Registration is recommended at least 10 minutes in advance of the event, and an archived replay will be available following the event. NorthWestern Energy - Delivering a Bright Future NorthWestern Energy provides essentia

The transaction sharpens AT&T's focus on building the strongest fiber and 5G network in the United StatesKey Takeaways:The transaction sharpens AT&T's focus and capital allocation on building the strongest network in the United States through continued investments in fiber and 5G, further aligning its portfolio with its long-term strategy of advanced connectivity and convergence.AT&T's effort to consolidate and modernize Mexico's second scaled wireless network has well positioned AT&T Mexico for its next phase of growth. These opportunities are best undertaken by a local operator who brings attractive assets to improve the overall customer value proposition.Transaction is expected to close i

SARATOGA, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ:CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that Johnny Wang, President and Chief Executive Officer, David Garcia, Senior Vice President of Finance, and Doug Atkinson, Senior Vice President of Global Sales, will present at the 20th Annual LD Micro Main Event, taking place October 19-21, 2026, at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Format: Company Presentation and 1x1 Investor Meetings Date/Time: Wednesday, October 21, 2026, at 9:00–9:25 am PT A webcast of the presentation will be streamed live at the

SAN JOSE, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc (NASDAQ:RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company’s management team will participate in a fireside chat at the upcoming Chardan Healthcare Conference. Details below: Chardan Healthcare Conference Date: Tuesday, October 20, 2026 at 1:00pm E.T.Location: New York, New YorkPresenter: Chief Executive Officer, Talat Imran, Chief Financial Officer, Nicholas Maestas, and Chief Business Officer, Kate McKinleyFormat: Fireside Chat and 1x1 Meetings Interested parties can access the live webcast for this conference from the Investor Relati

THORNTON, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- MYR Group Inc. ("MYR Group") (NASDAQ:MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United States and Canada, announced it will attend the Baird 2026 Global Industrial investor conference. MYR Group’s Chief Executive Officer, Rick Swartz, Chief Financial Officer, Kelly Huntington, and Vice President, Investor Relations and Treasurer, Jennifer Harper, will meet with institutional investors during the Baird 2026 Global Industrial Conference on November 12, 2026, in Chicago. This event is only available to Baird clients. About MYR Gr

VIENNA, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Inseego Corp. (NASDAQ:INSG), a global leader in wireless broadband solutions, today announced its participation in carrier evaluations of Licensed Band Radio (LBR) technology and related customer premises equipment (CPE) and access point (AP) solutions designed to address emerging broadband deployment opportunities. The initiative builds on the FastMile portfolio acquired from Nokia, which brought proven mmWave receiver technology, advanced RF and wireless engineering expertise, strategic carrier relationships, and extensive deployment experience across a broad range of fixed wireless access environments. As operators explore LBR technology, many

Public Voting Open October 13 - 20 to Select the Final 15 Finalists Torrid Holdings Inc. ("Torrid" or the "Company") (NYSE:CURV), a leading fashion destination for women sizes 8 to 30, today announced the top 30 semi-finalists from its 2026 Casting Call, as the brand searches for the next faces of Torrid. The semi-finalists were selected from more than 12,000 applicants following a nationwide search inviting women to step into the spotlight and showcase their confidence and individuality. The 30 semi-finalists range in age from 22 to 47 and represent communities all across the US and Canada. Together, they bring a diverse range of backgrounds, perspectives and personal styles to this ye

New repowering playbook and installer resources pair step-by-step business guidance with technical training and inverter flexibility for legacy-system upgrades. Tigo Energy, Inc. (NASDAQ:TYGO) ("Tigo" or "Company"), a leading provider of intelligent solar and energy software solutions, today announced that Tigo technology has helped enable over 11MW of solar repowering projects as demand grows for upgrades, replacement components, and services across the installed base of aging residential solar systems. To help installers capture this opportunity, Tigo is also introducing a practical repowering playbook and installer resources designed to support both business development and the technic

Key Facts At-a-Glance Who: Primech Holdings Limited (NASDAQ:PMEC), a Singapore-headquartered technology-driven facilities services and AI robotics group, represented by Company executives, at LD Micro Main Event XX, hosted by LD Micro, a wholly owned subsidiary of Freedom US Markets.What: A company presentation and one-on-one investor meetings on each of the conference’s three days.When: Presentation on Wednesday, October 21, 2026 at 2:30 PM Pacific Time; the conference runs October 19 to 21, 2026.Where: Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard, Los Angeles, California; live webcast at https://ldmicroevents.com/.Why it matters: Direct investor access to Primech’s two growth engin

Buda Juice, Inc. (NYSE:BUDA), creator and pioneer of the Ultra Fresh™ category in the supermarket fresh produce department, today announced that management will participate in the LD Micro 20th Annual Main Event, taking place October 20, 2026 at the Luxe Sunset Boulevard Hotel in Los Angeles, California.Horatio Lonsdale-Hands, Chief Executive Officer and Co-Founder of Buda Juice, is scheduled to host in-person one-on-one meetings with institutional investors throughout the conference and will deliver a corporate presentation as follows:LD Micro Main Event XX PresentationDate: Tuesday, October 20, 2026Time: 4:30 p.m. Pacific Time / 7:30 p.m. Eastern TimeLocation: Luxe Sunset Boulevard Hotel,

CAMBRIDGE, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (NASDAQ:WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in the "RNA Medicines: Next-Generation RNA Therapeutics" panel at Chardan’s 10th Annual Healthcare Conference in New York City on Tuesday, October 20, 2026 at 9:45 a.m. ET. A live webcast of the panel can be accessed by visiting "Investor Events" on the Investors section of the Wave Life Sciences website: https://ir.wavelifesciences.com/events-publications/events. A repl

CEO Stanton E. Ross to discuss the completed video solutions divestiture, and the company's live entertainment roadmap  OLATHE, KS, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Kustom Entertainment, Inc. (NASDAQ:KUST) ("Kustom" or the "Company"), a live entertainment and music festival company, today announced that Chief Executive Officer Stanton E. Ross will present at the 20th Annual LD Micro Main Event, taking place Oct. 19–21, 2026, at the Luxe Sunset Boulevard Hotel in Los Angeles. Mr. Ross will also hold one-on-one meetings with registered investors during the conference.  Presentation Details:  Event: LD Micro Main Event 20th Annual Date: Wednesday, Oct. 21, 2026 Time: 3:00 p.m. PT 5:00 p.m

MARSHALL, Texas, Oct. 13, 2026 /PRNewswire/ -- Nomadar Corp. ("Nomadar" or the "Company") (NASDAQ:NOMA), a Nasdaq-listed global sports, tourism, technology, and experiential infrastructure company, today announced it will host a virtual investor event on Wednesday, October 28, 2026, at 11:00 AM ET. The investor webinar (the "Webinar") will feature a panel discussion with Nomadar CEO Americas & Board Director, Joaquin Martin, Fox Soccer Academy ("FSA") Co-Founder, Managing Partner, and Technical Director, Christian Fuchs, and FSA's Co-Founder, Managing Partner, and Business Director, Raluca Gold-Fuchs.The Webinar follows Nomadar's and FSA's recent announcement of the signing of a definitive a

Revvity, Inc. (NYSE:RVTY), today announced it will present at the following investor conferences: 2026 Jefferies Global Healthcare Conference Tuesday, November 17, 2026 8:00 a.m. GMT – Prahlad Singh, president and chief executive officer 9th Annual Evercore Healthcare Conference Wednesday, December 2, 2026 9:10 a.m. ET – Prahlad Singh Attendees will receive an update on the Company and its strategic priorities during fireside chats. Live audio webcasts will be available on the Events section of the Company’s website. Replays of the presentations will be posted on the Revvity Investor Relations website after the events and will be available for at least 30 days. About Revvity At

EMERYVILLE, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (NASDAQ:MGX) (the "Company"), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today announced that Jian Irish, Ph.D., M.B.A., President and Chief Executive Officer of the Company, will participate in a panel discussion titled "Genome Editing: Next-Wave Platforms Beyond CRISPR 1.0" at the Chardan 10th Annual Healthcare Conference on Tuesday, October 20, 2026, at 10:30 a.m. ET, being held in New York, NY. A live webcast of the event will be made available on the "News & Events" page in the Investors section of the Company’s web

GAITHERSBURG, Md., Oct. 13, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), an AI company using its proprietary platform to turn complex biomedical data into actionable insights, today announced Vin Singh, Founder and Chief Executive Officer, will participate in the 20th Annual LD Micro Main Event being held October 19-21, 2026 at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Mr. Singh is scheduled to present to investors on Tuesday, October 20th at 12:30 p.m. PT. Interested parties are invited to watch the live webcast presentation here. In addition, the live webcast and replay can be accessed publicly on BullFrog AI’s Inv

CARMEL, Ind. and BURLINGTON, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (NASDAQ:MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Steve Hoerter, Chairman and Chief Executive Officer, and Sam Azoulay, M.D., Chief Medical Officer, will present at, and participate in, the following upcoming investor conferences: Guggenheim 3rd Annual Healthcare Innovation ConferenceDate: Tuesday, November 10, 2026Format: Fireside Chat and 1x1 meetingsTime: 11:00 – 11:25 a.m. EST Location: Boston, MA UBS Global Biophar